HutchMED (China) LIMITED (HMDCF) Total liabilities 2016–2025
HutchMED (China) LIMITED (HMDCF) total liabilities at each fiscal year-end, per SEC filings.
$501.8MFY2025 · since FY2016: $138.4M → $501.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $501.8M | -0.1% |
| FY2024 | $502.3M | -6.3% |
| FY2023 | $536.4M | +36.6% |
| FY2022 | $392.6M | +17.8% |
| FY2021 | $333.1M | +62.4% |
| FY2020 | $205.2M | +34.8% |
| FY2019 | $152.2M | +27.0% |
| FY2018 | $119.9M | +6.1% |
| FY2017 | $113.0M | -18.4% |
| FY2016 | $138.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More HMDCF financial trends
HMDCF RevenueHMDCF Net incomeHMDCF Net marginHMDCF Gross profitHMDCF Gross marginHMDCF Operating incomeHMDCF Operating marginHMDCF Operating cash flowHMDCF Free cash flowHMDCF Capital expendituresHMDCF Return on equityHMDCF Stock buybacksHMDCF Dividends paidHMDCF Total assetsHMDCF Shareholders’ equityHMDCF overview →